Nafamostat


CAS No. : 81525-10-2

81525-10-2
Price and Availability of CAS No. : 81525-10-2
Size Price Stock
5mg $190 Get quote
10mg $304 Get quote
25mg $495 Get quote
50mg $690 Get quote
100mg $950 Get quote
200 mg Get quote
500 mg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-B0190
M.Wt: 347.37
Formula: C19H17N5O2
Purity: >98 %
Solubility: 10 mM in DMSO
Introduction of 81525-10-2 :

Nafamostat, an anticoagulant, is a synthetic serine protease inhibitor. Nafamostat has anticancer and antivirus effect. Nafamostat induce apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1). Nafamostat can be used in the development of the pathological thickening of the arterial wall[1][2][3][4]. In Vitro:Nafamostat (10-80 μg/mL, 3-48 h) inhibits NF-κB activity by blocking IκBα phosphorylation in MDAPanc-28 cells[1].
Nafamostat (80 μg/mL, 24-48 h) induces apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1) in MDAPanc-28 cells[1].
Nafamostat (0.1-10 μM, 24 h) has suppressive effect on invasiveness in Panc-1 cells[2]. In Vivo:Nafamostat (10 mg/kg, Intraperitoneal injection, once a day for 18 days) exhibits favourable antiviral effects against Zika virus (ZIKV) infection in A129 mice[3].
Nafamostat (0.5-2.0 mg/mL (dissolved in saline), Intraperitoneal injection, once a day for 7 consecutive days) has inhibitory effect on neointimal formation after balloon injury of the rat carotid wall[4].

Your information is safe with us.